Concepedia

Luwei Han

LH

3

Publications

71

Citations

3

H-Index

2021

Active since

Affiliations

China Pharmaceutical University(Current)

Simcere Pharmaceutical (China)

Zhuhai People's Hospital

Jinan University

Luwei Han is an author at China Pharmaceutical University specializing in angiogenesis, drug discovery, and tumor biology.

Top concepts

Publications per year

2021–2021

3

Publications

3

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer

Luwei Han, Xiaomeng Zhang, Zhiqiang Wang et al. · Frontiers in Pharmacology · 2021 · 28 citations · Full text

Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China

Zhiqiang Wang, Zhibo Zhang, Yong Li et al. · Acta Pharmaceutica Sinica B · 2021 · 25 citations · Full text

C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma

Mei Yang, Yanhong Su, Zhiqiang Wang et al. · Biochemical Pharmacology · 2021 · 18 citations · Full text

, , +18

Rows per page

1–3 of 3